Literature DB >> 23313083

The characteristics of Klebsiella pneumoniae that produce KPC-2 imported from Greece.

Wilson W Chan1, Gisele Peirano, Daniel J Smyth, Johann D D Pitout.   

Abstract

We report a case of lower urinary tract infection due to KPC-2-producing K. pneumoniae (KpCG02) in an elderly patient who had recently been hospitalized in Greece. The patient was treated successfully on an outpatient basis by removing the Foley catheter and with a prophylactic dose of gentamicin. KpCG02, which belonged to ST258, contained repFII plasmids that tested positive for the vagCD addiction system and the uge, wabG, urea, mrkD, and fimH virulence factors. This case reemphasizes the need for vigilance screening for carbapenem-resistant Gram negatives in patients with a history of travel to endemic areas, such as Greece.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23313083     DOI： 10.1016/j.diagmicrobio.2012.12.003

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  8 in total

Review 1.  The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.

Authors:  Amy J Mathers; Gisele Peirano; Johann D D Pitout
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

Review 2.  Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance.

Authors:  Johann D D Pitout; Patrice Nordmann; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

3.  Expansion and evolution of a virulent, extensively drug-resistant (polymyxin B-resistant), QnrS1-, CTX-M-2-, and KPC-2-producing Klebsiella pneumoniae ST11 international high-risk clone.

Authors:  Leonardo Neves Andrade; Lúcia Vitali; Gilberto Gambero Gaspar; Fernando Bellissimo-Rodrigues; Roberto Martinez; Ana Lúcia Costa Darini
Journal:  J Clin Microbiol       Date:  2014-05-07       Impact factor: 5.948

Review 4.  Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases.

Authors:  L Silvia Munoz-Price; Laurent Poirel; Robert A Bonomo; Mitchell J Schwaber; George L Daikos; Martin Cormican; Giuseppe Cornaglia; Javier Garau; Marek Gniadkowski; Mary K Hayden; Karthikeyan Kumarasamy; David M Livermore; Juan J Maya; Patrice Nordmann; Jean B Patel; David L Paterson; Johann Pitout; Maria Virginia Villegas; Hui Wang; Neil Woodford; John P Quinn
Journal:  Lancet Infect Dis       Date:  2013-09       Impact factor: 25.071

5.  Travel-related carbapenemase-producing Gram-negative bacteria in Alberta, Canada: the first 3 years.

Authors:  Gisele Peirano; Jasmine Ahmed-Bentley; Jeff Fuller; Joseph E Rubin; Johann D D Pitout
Journal:  J Clin Microbiol       Date:  2014-03-05       Impact factor: 5.948

6.  Molecular characterization of Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae in Ontario, Canada, 2008-2011.

Authors:  Nathalie Tijet; Prameet M Sheth; Olga Lastovetska; Catherine Chung; Samir N Patel; Roberto G Melano
Journal:  PLoS One       Date:  2014-12-30       Impact factor: 3.240

Review 7.  Carbapenem Resistance: A Review.

Authors:  Francis S Codjoe; Eric S Donkor
Journal:  Med Sci (Basel)       Date:  2017-12-21

Review 8.  Travel-Related Antimicrobial Resistance: A Systematic Review.

Authors:  Hamid Bokhary; Krisna N A Pangesti; Harunor Rashid; Moataz Abd El Ghany; Grant A Hill-Cawthorne
Journal:  Trop Med Infect Dis       Date:  2021-01-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.